University:
West Coast University
Course:
NURS 180 | Pharmacology
Academic year:

2022
Views:

304

Pages:

2
Author:

gewoekerdodx

PROPAFANONE PROPRANOLO PROSTAGLANDIN E1 Name/Class: PROPAFANONE (Rythmol)/Antidysrhythmic Description: Propafanone is an antidysrhythmic that stabilizes the myocardial membranes, reduces automaticity and the rate of single and multiple PVCs, and suppresses ventricular tachycardia. Indications: Ventricular and supraventricular dysrhythmias. Contraindications: Hypersensitivity, uncontrolled CHF, cardiogenic shock, sick sinus syndrome, AV block, bradycardia, hypotension, bronchospastic disorders, electrolyte imbalances, non–life-threatening dysrhythmias, COPD, or nursing mothers. Precautions: CHF, AV block, hepatic or renal impairment, elderly, or pregnancy. Dosage/Route: 150 to 300 mg PO/8 hours or 1 to 2 mg/kg IV at 10 mg/min. Name/Class: PROPRANOLOL (Inderal)/Beta Blocker Description: Propranolol is a nonselective beta blocker affecting both bronchial and cardiac sites. It reduces heart rate, myocardial irritability, contraction force, cardiac output, and blood pressure. Indications: Ventricular fibrillation and pulseless ventricular tachycardia refractory to lidocaine and bretylium and selected SVTs. Contraindications: 2nd- and 3rd-degree heart blocks, CHF, cor pulmonale, sinus bradycardia, cardiac impairment, cardiogenic shock, bronchospasm, or bronchial asthma, COPD, adrenergic-augmenting psychotropic or MAO inhibitors. Precautions: Peripheral vascular disease, bee sting allergy, mild COPD, renal or hepatic impairment, diabetes, hypoglycemia, myasthenia gravis, WPW syndrome, or major surgery. Dosage/Route: 1 to 3 mg slow IV (over 2 to 5 min), not to exceed 1 mg/min, may repeat/2 min to 0.1 mg/kg. Ped: 0.01 mg/kg slow IV. Name/Class: PROSTAGLANDIN E1 (Prostin VR Pediatric)/Vasodilator Description: Prostaglandin E1 is derived from fatty acids and causes vasodilation, inhibits platelet aggregation, and stimulates intestinal and uterine smooth muscles. It also helps maintain ductus arteriosus patency in newborn infants. Indications: Infant cyanotic heart disease. Contraindications: Precautions: Constant respiratory monitoring is required. Dosage/Route: Infant: 0.05 to 0.1 mcg/kg/min IV/IO.